We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serum Markers in Preeclamptic Women

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01361737
First Posted: May 27, 2011
Last Update Posted: July 6, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Oslo University Hospital
  Purpose
Could possible markers in serum obtained in the first trimester predict the human-pregnancy specific disorder pre-eclampsia?

Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Study Start Date: January 1999
Study Completion Date: May 2004
Primary Completion Date: January 1999 (Final data collection date for primary outcome measure)
Groups/Cohorts
preeclampsia
  • Control group: 86 healthy women not developing preeclampsia (PE)
  • Case group: 43 women developing PE

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Norwegian pregnant women
Criteria

Inclusion Criteria:

  • previous healthy

Exclusion Criteria:

  • Previous inflammatory diseases
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01361737


Locations
Norway
Oslo University Hospital, Rikshospitalet
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
  More Information

Responsible Party: Oslo University Hospital, Rikshospitalet, OsloUH
ClinicalTrials.gov Identifier: NCT01361737     History of Changes
Other Study ID Numbers: NOSERPE11
First Submitted: May 25, 2011
First Posted: May 27, 2011
Last Update Posted: July 6, 2011
Last Verified: May 2011

Keywords provided by Oslo University Hospital:
Preeclampsia
serological bio-bank
adiponectin
suPAR

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications